Abstract
Small interfering RNAs (siRNAs) represent a promising approach for gene therapy due to their ability to specifically and efficiently silence target genes. However, challenges such as enzymatic degradation, immune activation, and difficulties in crossing biological barriers underscore the need for effective delivery systems with clinical viability. This project aims to develop human serum …